The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

Autor: H, Lepor, W O, Williford, M J, Barry, C, Haakenson, K, Jones

Publikováno v: The Journal of urology. 160(4)

We determine the effect of placebo, finasteride, terazosin and a combination of drugs on bother due to symptoms, quality of life and patient perception of improvement, and identify baseline clinical factors that predict clinical response to medical t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::96662995952f26f0fd13addd7a4fca9d
https://pubmed.ncbi.nlm.nih.gov/9751354

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

Autor: H, Lepor, W O, Williford, M J, Barry, M K, Brawer, C M, Dixon, G, Gormley, C, Haakenson, M, Machi, P, Narayan, R J, Padley

Publikováno v: The New England journal of medicine. 335(8)

Men with benign prostatic hyperplasia can be treated with alpha 1-adrenergic-antagonist drugs that relax prostatic smooth muscle or with drugs that inhibit 5 alpha-reductase and therefore reduce tissue androgen concentrations. However, the effects of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::22c497dbcbba8a6c3652a2cb29f541bf
https://pubmed.ncbi.nlm.nih.gov/9005318

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Performance of Polygenic Risk Scores for Primary Open-Angle Glaucoma in Populations of African Descent.

Autor: Chang-Wolf JM; Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands.; Department of Ophthalmology, Duke University, Durham, North Carolina.; Department of Medicine, Duke University Medical Center, Durham, North Carolina., Kinzy TG; Cleveland Institute for Computational Biology, Case Western Reserve University, Cleveland, Ohio.; Department of Population & Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio.; Research Service, VA Northeast Ohio Healthcare System, Cleveland, Ohio.; Department of Pharmacology & Toxicology, Brody School of Medicine, East Carolina University, Greenville, North Carolina.; Center for Health Disparities, Brody School of Medicine, East Carolina University, Greenville, North Carolina., Driessen SJ; Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands.; Department of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands., Cruz LA; Cleveland Institute for Computational Biology, Case Western Reserve University, Cleveland, Ohio.; Department of Population & Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio., Iyengar SK; Cleveland Institute for Computational Biology, Case Western Reserve University, Cleveland, Ohio.; Department of Population & Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio.; Research Service, VA Northeast Ohio Healthcare System, Cleveland, Ohio., Peachey NS; Research Service, VA Northeast Ohio Healthcare System, Cleveland, Ohio.; Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio.; Department of Ophthalmology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio., Aung T; Singapore Eye Research Institute, Singapore., Khor CC; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore., Williams SE; Division of Ophthalmology, Department of Neurosciences, University of the Witwatersrand, Johannesburg, South Africa., Ramsay M; Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Olawoye O; Department of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria., Ashaye A; Department of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria., Klaver CCW; Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands.; Department of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands.; Department of Ophthalmology, Radboud University Medical Centre, Nijmegen, Gelderland, the Netherlands.; Institute of Molecular and Clinical Ophthalmology, Basel, Switzerland., Hauser MA; Department of Ophthalmology, Duke University, Durham, North Carolina.; Department of Medicine, Duke University Medical Center, Durham, North Carolina.; Singapore Eye Research Institute, Singapore., Thiadens AAHJ; Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands.; Department of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands., Cooke Bailey JN; Cleveland Institute for Computational Biology, Case Western Reserve University, Cleveland, Ohio.; Department of Population & Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio.; Research Service, VA Northeast Ohio Healthcare System, Cleveland, Ohio.; Department of Pharmacology & Toxicology, Brody School of Medicine, East Carolina University, Greenville, North Carolina.; Center for Health Disparities, Brody School of Medicine, East Carolina University, Greenville, North Carolina., Bonnemaijer PWM; Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands.; Department of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands.; The Rotterdam Eye Hospital, Rotterdam, the Netherlands.

Publikováno v: JAMA ophthalmology [JAMA Ophthalmol] 2024 Nov 14. Date of Electronic Publication: 2024 Nov 14.